Progress in immunotherapy for children with anti-N-methyl-D-aspartate receptor encephalitis
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune encephalitis that was reported in recent years. At present, there remains no unified treatment regimen for the children and adolescents with this disease around the world. Immunotherapy is still the preferred way of treatment, mainly including first-line immunotherapy, second-line immunotherapy, and long-term immunotherapy. In recent years, some researchers have tried new immunosuppressants or modified immunotherapy regimens to improve the treatment outcome of the patients. This article summarizes related immunotherapy regimens, as well as the future direction of research on immunotherapy for anti-NMDAR encephalitis.

    Reference
    Related
    Cited by
Get Citation

张展, 方峰.儿童抗N-甲基-D-天门冬氨酸受体脑炎免疫治疗进展[J].中国当代儿科杂志英文版,2018,20(9):781-785

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 22,2018
  • Revised:July 06,2018
  • Adopted:
  • Online: September 25,2018
  • Published:
Article QR Code